Delay in AstraZenica vaccine approval

Thursday, 4 February 2021 09:58

In yet another blow to Switzerland’s vaccine roll out – the regulator Swissmedic, says it does not have enough information to allow the use of the AstraZeneca vaccine.

It was being reported last month approval was imminent. The EU and the UK have approved it.

Swissmedic says it’s waiting for results from a phase 3 trial under way in the Americas before making a final decision.

The government is preparing for a further two vaccines to become available. It has pre-ordered five million doses from the German firm Curevac and a further 6 million from the US firm Novamax – which is showing promising effectiveness from the UK and South African variants. But it may not be available before the summer.

More from Bitesize News

Geneva blindsided by car tax chaos

The Geneva government has been blindsided by the effect of the new car tax and are now scrabbling to explain why.
Govt backs foie gras

The Federal Council has come down firmly on the issue of foie gras.
Fairmont to close for 3 yrs

The Geneva luxury Fairmont Hotel on the Quai Wilson will close its doors for renovation next month. The work could last for up to three years.
Long term plans for atom waste dump

The time frames are immense – but plans have been revealed on a new nuclear waste storage site, which, by law, has to be viable for a million years.
A12 closed after snow triggering crash

A section of the A12 autoroute running between Vevey and Châtel-St-Denis was closed over night following a multicar pile up, caused by the snow.
Woman seeks life saving savior

A young woman in Geneva has launched a search for the woman who saved her life when she was swept away by the Rhone last spring.